The Neuropsychiatric Drug Development Summit returns for its eighth year as the industry’s flagship forum capturing advancements across discovery, preclinical, translational, clinical, and regulatory ...

Despite a definitive pullback among popular quantum computing stocks, they seem to be picking up where they left off in 2025, with the benchmark Defiance Quantum ETF (ticker: QTUM) up 6% year to date ...